MGNet: New Assay Evaluates Acetylcholine Receptor Autoantibody–Mediated Complement Activity in Myasthenia Gravis
15 ago 2022 ·
1 min. 42 sec.
![MGNet: New Assay Evaluates Acetylcholine Receptor Autoantibody–Mediated Complement Activity in Myasthenia Gravis](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/8bf2b20a450f0bdef3978317f49fd90d.jpg)
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal Neuroimmunology & Neuroinflammation on April 26, 2022, titled "Heterogeneity...
mostra di più
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal Neuroimmunology & Neuroinflammation on April 26, 2022, titled "Heterogeneity of Acetylcholine Receptor Autoantibody–Mediated Complement Activity in Patients With Myasthenia Gravis."
Read the paper here: https://nn.neurology.org/content/9/4/e1169
Learn more about MGNet: https://www.rarediseasesnetwork.org/mgnet
mostra meno
Read the paper here: https://nn.neurology.org/content/9/4/e1169
Learn more about MGNet: https://www.rarediseasesnetwork.org/mgnet
Informazioni
Autore | RDCRN |
Sito | - |
Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company